Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Endocyte is a privately-held biotechnology company with several promising products in clinical development to treat cancer and other serious illnesses. The company’s proprietary technology platform is based on “receptor-targeted therapeutics.” Targeting allows Endocyte to identify and deliver drugs directly into tumor cells or other diseased cells. Building on research in cellular biology that has led to a new understanding of disease targeting and cell pathways, Endocyte is advancing a pipeline of targeted diagnostic, immunotherapy, and chemotherapy drugs. The company’s therapeutic focus is derived from groundbreaking research initiated in the mid-1980s by Philip Low, Ph.D., a biochemist at Purdue University. In 1988, ( www.endocyte.com )
Endocyte Inc.
3000 Kent Avenue Suite A1-100
West Lafayette, Indiana 47906
USA
Tel: (765) 463-7175
Fax: (765) 463-9271